LTI-02

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLTI-02
Drug Alias NameLTI-02
ClassificationBiologics
Mechanisms of ActionUrokinase plasminogen activator modulators
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Texas SystemLung Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAcute Lung Injury

Other Information

ATC CodeN/A
Related LinksN/A